MedPath

Prognosis of Low-grade Endometrial Stromal Sarcoma

Recruiting
Conditions
Survival Outcomes
Recurrence
Hormone Therapy
Adjuvant Therapy
Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis)
Fertility-sparing Surgery
Fertility Outcomes
Registration Number
NCT05310318
Lead Sponsor
Lei Li
Brief Summary

This study is to investigate the survival outcomes and fertility outcomes in patients with uterine low-grade endometrial stromal sarcoma (LGESS) treated in Peking Union Medical College Hospital. All primary and recurrent LGESS patients will be enrolled. The study will collect retrospectively data consisting of epidemiological characteristics, surgical, medical treatment and adjuvant therapy. Details about recurrence, mortality, pregnancy and obstetrical outcomes are also followed as primary endpoints. Fertility-sparing procedures, including uterine-sparing and ovary-sparing surgeries will be recorded specifically.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Aged 18 years or older
  • Confirmed of LGESS
  • Acceptance of surgical treatment for LGESS
  • With detailed follow-up outcomes
Exclusion Criteria
  • Not meeting all of the inclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Progression-free survivalOne year

Progression-free survival after surgery

Pregnancy rateOne year

Pregnancy rate after surgery in patients with fertility-sparing patients

Overall survivalOne year

Overall survival after surgery

Secondary Outcome Measures
NameTimeMethod
Full-term pregnancy rateOne year

Full-term pregnancy rate after surgery in patients with fertility-sparing patients

Miscarriage rateOne year

Miscarriage rate after surgery in patients with fertility-sparing patients

Trial Locations

Locations (1)

Lei Li

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath